The short version of thymalfasin fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-10-13 and is reviewed periodically as new material appears.
Most published studies on thymosin alpha-1 report changes in immune measurements rather than clinical outcomes, and findings differ across designs and populations. Whether the peptide signals through one defined receptor or through several less specific interactions remains an open question. Its reported circulation half-life of a few hours complicates comparison of dosing schedules across trials. Mechanistic claims are frequently drawn from isolated cell cultures, and how far those results extend to whole organisms is unresolved.
Thymosin alpha-1 is a synthetic peptide of 28 amino acids whose sequence matches the amino-terminal region of prothymosin alpha. The chain is acetylated at its first residue and contains one disulfide bridge between two cysteine residues, which folds the molecule into a compact loop. Its molecular formula, C129H215N33O55, corresponds to a monoisotopic mass of roughly 3,106 daltons. Material used in laboratories is made by solid-phase synthesis rather than isolated from animal tissue.
Whether the free 28-residue peptide circulates in human tissue remains debated. The best-documented human source is prothymosin alpha, a larger acidic protein that carries the sequence at its N-terminus. Reports of measurable peptide levels in serum and lymphoid tissue exist, yet some of that signal may come from cross-reacting fragments or from the parent protein. Most reviews therefore treat prothymosin alpha as the established human molecule and describe independent circulation of the small peptide as an unresolved question.
Immunological studies connect the peptide to multiple parts of the immune response. It has been reported to engage Toll-like receptor signaling, to promote dendritic cell maturation, and to influence the balance of T helper cell subsets. Changes in natural killer cell activity and in cytokine release appear in cell culture and animal models. These observations describe broad immunomodulatory behavior rather than a single defined receptor target, and the primary molecular interaction has not been settled.
Thymosin alpha-1 is a synthetic 28-amino-acid peptide whose sequence was first identified in extracts of bovine thymus tissue during the 1970s. The chain carries an acetyl group on its N-terminal serine. Its acidic residue content is high, which produces strong water solubility and an isoelectric point well below neutrality. Material supplied for laboratory and clinical use is manufactured by solid-phase peptide synthesis rather than purified from animal tissue. Different salt forms, such as the acetate, alter the counter-ion content without changing the peptide backbone.
| Property | Value | Notes |
|---|---|---|
| Class | Synthetic peptide | 28 residues; not a small-molecule compound |
| Molecular mass | About 3,106 Da | Monoisotopic mass of the unmodified chain |
| N-terminal group | Acetylated serine | Present in both native and synthetic forms |
| Secondary structure | Disulfide-constrained loop | One bridge between two cysteine residues |
| Typical source | Solid-phase synthesis | Early isolates came from bovine thymus extracts |
Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Results across trials have been mixed, and several studies were small or conducted under differing protocols. Regulatory status varies by country, and the compound is not approved in every jurisdiction where it is studied. Evidence for any single indication should be read with attention to sample size and endpoint choice.
Thymosin alpha-1 is a 28-residue peptide first isolated from thymus tissue in the 1970s. It corresponds to the N-terminal portion of thymosin beta-4, from which it is cleaved in vivo. The peptide carries an acetyl group at its N-terminus, a modification that affects its charge and stability. Synthetic material produced by solid-phase peptide synthesis is chemically identical to the natural fragment and is the form used in research and clinical studies.
The peptide is generated in cells by cleavage of prothymosin alpha, a larger acidic protein encoded by the PTMA gene. Prothymosin alpha is expressed in many tissues, not only in the thymus, and its functions include nuclear roles in chromatin-related processes. The 28-residue fragment corresponds to the N-terminal portion of that precursor. How the cleavage occurs and how the fragment's concentration is regulated remain open questions; circulating amounts are small and difficult to measure reliably with routine assays.
Thymosin alpha 1 is a short peptide first isolated from bovine thymus tissue in the early 1970s during fractionation work aimed at identifying factors that influence T cell development. It belongs to a family of acidic thymic peptides, and the original preparations contained several components that were later separated by chromatography. The compound is now produced synthetically rather than extracted from tissue, which removes batch variability tied to animal sourcing. Researchers describe it as an immunomodulatory peptide because laboratory studies show effects on several cell types of the innate and adaptive immune systems.
Within the immune system, the peptide acts on several cell types rather than a single target. Reported activities include promotion of T-cell maturation, enhancement of natural killer cell activity, and modulation of cytokine production by dendritic cells and macrophages. Some of these effects appear to operate through toll-like receptor signaling, though the precise receptor-level mechanism remains debated. Whether the observed immune changes translate into clinical benefit is a separate question and depends on the indication studied.
The peptide was described in the 1970s as a component of thymic extracts, and early research focused on restoring immune function in immunodeficiency states. A synthetic version entered clinical development in the 1980s and is approved as a drug in several countries for conditions such as chronic hepatitis B and certain immunodeficiencies. Approval status varies widely by jurisdiction, and in the United States it is not an approved therapeutic. Regulatory and clinical positions differ, so statements about efficacy should be tied to specific indications and studies.
Thymosin alpha-1 is a synthetic peptide of 28 amino acids, corresponding to the N-terminal fragment of prothymosin alpha. Its sequence begins with acetylation at the N-terminus, a modification that affects stability and receptor interaction. The peptide is acidic, with a calculated isoelectric point near 4.2, and carries no disulfide bonds, so its secondary structure is largely flexible in solution. Molecular mass is approximately 3108 daltons. The native form was first isolated from bovine thymus tissue, while pharmaceutical material is produced by solid-phase peptide synthesis.
== Physiology == In both cardiac and skeletal muscles, muscular force production is controlled primarily by changes in intracellular calcium concentration. In general, when calcium rises, the muscles contract and, when calcium falls, the muscles relax. Troponin is a component of thin filaments (along with actin and tropomyosin), and is the protein complex to which calcium binds to trigger the production of muscular force. Troponin has three subunits, TnC, TnI, and TnT, each playing a role in force regulation.. Under resting intracellular levels of calcium, tropomyosin covers the active actin sites to which myosin (a molecular motor organized in muscle thick filaments) binds in order to generate force. When calcium becomes bound to specific sites in the N-domain of TnC, a series of protein structural changes occurs, such that tropomyosin is rolled away from myosin-binding sites on actin, allowing myosin to attach to the thin filament and produce force and shorten the sarcomere. Individual subunits serve different functions:
He responded, "Not even a little bit. The only thing that matters when I’m talking about Iran — they can't have a nuclear weapon. I don’t think about Americans’ financial situation. I don't think about anybody. I think about one thing — we cannot let Iran have a nuclear weapon. That's all." He later told Fox News in an interview regarding his previous statement, "That's a perfect statement. I'd make it again." On 25 May, Trump said that any peace agreement with Iran must be tied to the Abraham Accords, stating that it "should be mandatory" for Saudi Arabia, Qatar, and Pakistan to establish diplomatic ties with Israel, in addition to Egypt, Jordan, and Turkey, which already have ties with Israel. On 1 June, following the shutdown of further talks by Iran due to planned Israeli attacks on Beirut, he told CNBC that he did not care and claimed that the negotiation process "started to get very boring". Later the same day, he claimed to have a "very productive call" with Netanyahu and Hezbollah to pause attacks on each other and reenable US talks with Iran.
Red blood cells of non-mammalian vertebrates are flattened and ovoid in form, and retain their cell nuclei. There is considerable variation in the types and proportions of white blood cells; for example, acidophils are generally more common than in humans. Platelets are unique to mammals; in other vertebrates, small nucleated, spindle cells called thrombocytes are responsible for blood clotting instead.
The GlyR agonism of sarcosine is relevant at concentrations frequently used in experimental settings (0.5–2 mM), complicating the pharmacological interpretation. Aside from effects on glycine-related structures and NMDA receptors, sarcosine has been shown to modulate AMPA receptor function and downstream mTOR signalling in rodent models of depression. Long-term sarcosine administration (21 days) ameliorated chronic unpredictable stress-induced depressive behaviour in rats In the rat forced swim test, a single systemic dose of sarcosine produced rapid antidepressant-like effects accompanied by increased phosphorylation of mTOR and its upstream kinases in the hippocampus, and these behavioural and molecular effects were abolished by pretreatment with the AMPA receptor antagonist NBQX or the mTOR inhibitor rapamycin. Sarcosine also increased phosphorylation of the GluR1 subunit at the protein kinase A site Ser845, a change commonly interpreted as enhanced AMPA receptor membrane insertion. Cryo-EM study published in 2025 resolved the structure of human GlyT1 in complex with sarcosine at 2.8 Å resolution, revealing the transporter in an occluded conformation.
Sources: en.wikipedia.org
The thorough pre-operative medical and surgical histories, and the physical examination of the patient's periorbital area (eyebrow-to-cheek-to-nose), determine if the patient can safely undergo a blepharoplasty procedure to feasibly resolve (correct or modify, or both) the functional and aesthetic indications presented by the patient. Sequentially, lower eyelid blepharoplasty can successfully address the anatomic matters of excess eyelid skin, slackness of the eye-muscles and of the orbital septum (palpebral ligament), excess orbital fat, malposition of the lower eyelid, and prominence of the nasojugal groove, where the orbit (eye socket) meets the slope of the nose. Concerning the upper eyelid, a blepharoplasty procedure can resolve the loss of peripheral vision, caused by the slackness of the upper-eyelid skin draping over the eyelashes; the outer and the upper portions of the field of vision of the patient are affected and cause him or her difficulty in performing mundane activities such as driving an automobile and reading a book.
=== Special populations === Diphenhydramine is secreted in breast milk. It is expected that low doses of diphenhydramine taken occasionally will cause no adverse effects in breastfed infants. Large doses and long-term use may affect the baby or reduce breast milk supply, especially when combined with sympathomimetic drugs, such as pseudoephedrine, or before the establishment of lactation. A single bedtime dose after the last feeding of the day may minimize the harmful effects of the medication on the baby and the milk supply. Still, non-sedating antihistamines are preferred. Paradoxical reactions to diphenhydramine have been documented, particularly in children, and it may cause excitation instead of sedation. Topical diphenhydramine is sometimes used, especially for people in hospice. This use is without indication, and topical diphenhydramine should not be used as treatment for nausea because research has not shown that this therapy is more effective than others.
6 November A PAVN sapper attack on Firebase St. George occupied by the 1st Battalion, 14th Infantry and 1st Battalion, 9th Artillery resulted in nine U.S. killed. MACV announced that it was holding back on sending U.S. ground forces to reinforce Duc Lap Camp as a test of the ARVN's abilities to handle higher intensity combat. The House Foreign Affairs Committee approved a resolution supporting Nixon's Vietnam policy.
=== Children === The infant lamina propria is composed of only one layer, as compared to three in the adult, and there is no vocal ligament. The vocal ligament begins to be present in children at about four years of age. Two layers appear in the lamina propria between the ages of six and twelve, and the mature lamina propria, with the superficial, intermediate and deep layers, is only present by the conclusion of adolescence. As vocal fold vibration is a foundation for vocal formants, this presence or absence of tissue layers influences a difference in the number of formants between the adult and pediatric populations. In females, the voice is three tones lower than the child's and has five to twelve formants, as opposed to the pediatric voice with three to six. The length of the vocal fold at birth is approximately six to eight millimeters and grows to its adult length of eight to sixteen millimeters by adolescence. The infant vocal fold is half membranous or anterior glottis, and half cartilaginous or posterior glottis. The adult fold is approximately three-fifths membranous and two-fifths cartilaginous.
He played Police Chief Steve Kimbrough in Piranha Part Two: The Spawning (1982), the astronaut Walter Schirra in The Right Stuff (1983), actor Charles Bronson in the television film Reason for Living: The Jill Ireland Story (1991), and a cameo appearance as The King in Super Mario Bros. (1993). When James Cameron was writing The Terminator (1984), he originally envisioned Henriksen, with whom he had worked on Piranha II, as playing the title role, a cyborg. The role ultimately went to Arnold Schwarzenegger. Henriksen does appear in the film as Hal Vukovich, a Detective in the Los Angeles Police Department.
Sources: en.wikipedia.org
== Description == The adult lesser mealworm beetle is roughly 6 mm long and widely oval in shape. It is shiny black or brown with reddish brown elytra, the color variable among individuals and changing with age. Much of the body surface is dotted with puncture-like impressions. The antennae are paler at the tips and are covered in tiny, yellowish hairs. The elytra have shallow longitudinal grooves. The eggs are narrow, whitish or tan, and about 1.5 mm long. The larvae somewhat resemble other mealworms, such as the common mealworm (Tenebrio molitor), but are smaller, measuring up to 11 mm long at the final subadult stage. They are tapering and segmented, with three pairs of legs toward the front end, and whitish when newly emerged from the egg and darken to a yellow-brown. They become pale when preparing to molt between instar stages six to 11 instars occur.
In addition, autoimmune diabetes is characterized by a loss of islet-specific sympathetic innervation. This loss constitutes an 80–90% reduction of islet sympathetic nerve endings, happens early in the progression of the disease, and is persistent through the life of the patient. It is linked to the autoimmune aspect of type 1 diabetics and fails to occur in type 2 diabetics. Early in the autoimmune event, the axon pruning is activated in the islet sympathetic nerves. Increased BDNF and ROS that result from insulitis and beta cell death stimulate the p75 neurotrophin receptor (p75NTR), which acts to prune off axons. Axons are normally protected from pruning by activation of tropomyosin receptor kinase A (Trk A) receptors by NGF, which in islets is primarily produced by beta cells. Progressive autoimmune beta cell destruction, therefore, causes both the activation of pruning factors and the loss of protective factors to the islet sympathetic nerves. This unique form of neuropathy is a hallmark of type 1 diabetes, and plays a part in the loss of glucagon rescue of severe hypoglycemia.
== External links == Wladimir Lyra Archived 12 November 2023 at the Wayback Machine, "Living in a comet: How to build a Dyson treehouse". Las Cruces Sun-News, March 2020. Dyson Tree – Innovative Technologies from Science Fiction for Space Application.
In 1973, Cold Storage's Pasaraya Malaysia, a joint venture of Cold Storage's subsidiary Supermarkets Malaysia and "Malaysian interests" was responsible for the construction of Jaya Supermarket in Petaling Jaya, set to be completed in April 1974. In 1985, Cold Storage Malaysia opened its first Majik Market store in Bangsar Baru, Kuala Lumpur, It operated under a franchise from Mumford Inc of Atlanta, USA, which complements its existing Jaya Supermarket chain but differ in concept and management. Due to competition from 7-Eleven, whose Malaysian franchise was then operated by the Antah Holdings group, Cold Storage Malaysia phased out Majik Market as part of its streamlining process. Cold Storage Malaysia, along with Peremba, Gaya Timur and Jusco were responsible for the initial version of Jaya Jusco "superstores" in 1985, with three stores in Dayabumi, Taman Tun Dr Ismail and Subang Jaya. In 1987, Cold Storage Malaysia, which had been through a difficult financial phase in the previous three years, had a change in management with some senior executives leaving. In 1992, DFI Retail Group purchased the company, although no major changes were made to the Cold Storage brand. Cold Storage started the Fresh Food Distribution Centre in Singapore in 1999, a composite multi-temperature warehousing for fresh and frozen food distribution. In 2023, DFI Retail Group divested its Malaysian food retailing business (including Cold Storage brand in that country) to Macrovalue Sdn Bhd.
Hurley showed tremendous form throughout the TAC Cup, showing his all-round quality for the Northern Knights. He was named All-Australian in 2007 and backed it up with another selection after the 2008 AFL Under 18 Championships and was also selected in the TAC Cup Team of the Year in both seasons. He made his debut against the Port Adelaide Power in round 1, 2009, and was nominated twice as the AFL Rising Star nominee, in round 20 of that season, and round 18 the following year, both times against St Kilda. After his match-winning four goal performance against Hawthorn in round 22, 2009, Leigh Matthews said, "Very few young talls have the physical maturity to match it with their older and stronger opponents, which is why the brilliant early form of young Bomber Michael Hurley is quite amazing." Ahead of the 2010 season, Hurley inherited the famous number 18 guernsey from retired club great Matthew Lloyd. The following four seasons saw Hurley's form fluctuate due to injury and the constant shuffling of his position in the team between both ends of the ground. He averaged 22 goals per season, and spent just as much time playing in the back line on some of the opposition's best key forwards, where his precise kicking and attacking flair out of the back half were noticeable on numerous occasions. The 2014 season brought with it a permanent role for Hurley as a key defender, the position for which he was initially drafted. This newfound positional consistency allowed him to really begin to shine as a footballer.
Sources: en.wikipedia.org
Its sequence corresponds to the amino-terminal portion of prothymosin alpha, a larger protein present in many cell types. The isolated 28-residue peptide is a fragment of that protein rather than a separately encoded molecule, and laboratory material is produced by synthesis.
The single bridge between two cysteine residues holds the chain in a folded loop that influences its shape and its behavior in solution. Loss of the bridge through reduction or oxidation shifts chromatographic retention and is tracked during stability work.
It is a defined 28-residue sequence derived from a larger precursor, whereas many other thymic preparations are mixtures of several polypeptides. Its acetylated amino terminus and single disulfide bridge distinguish it chemically from unrelated thymic extracts.
It is usually described as an immunomodulatory peptide rather than a classic circulating hormone. No endocrine gland is known to release it as a primary secretory product, and its measured presence in blood is not firmly established.